Cutler Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,100
| Closed | – | – | 2450 |
|
|
2022
Q4 | $0 | Sell |
1,100
-2,100
| -66% | – | ﹤0.01% | 2599 |
|
|
2022
Q3 | $5K | Buy |
3,200
+1,300
| +68% | +$2.03K | ﹤0.01% | 1576 |
|
|
2022
Q2 | $3K | Buy |
1,900
+1,000
| +111% | +$1.58K | ﹤0.01% | 1681 |
|
|
2022
Q1 | $2K | Sell |
900
-2,200
| -71% | -$4.89K | ﹤0.01% | 1848 |
|
|
2021
Q4 | $14K | Sell |
3,100
-400
| -11% | -$1.81K | ﹤0.01% | 1587 |
|
|
2021
Q3 | $26K | Sell |
3,500
-1,700
| -33% | -$12.6K | ﹤0.01% | 1454 |
|
|
2021
Q2 | $50K | Buy |
5,200
+500
| +11% | +$4.81K | ﹤0.01% | 1235 |
|
|
2021
Q1 | $38K | Hold |
4,700
| – | – | ﹤0.01% | 1264 |
|
|
2020
Q4 | $32K | Buy |
4,700
+290
| +7% | +$1.97K | ﹤0.01% | 1135 |
|
|
2020
Q3 | $49K | Sell |
4,410
-1,690
| -28% | -$18.8K | ﹤0.01% | 891 |
|
|
2020
Q2 | $38K | Buy |
6,100
+5,800
| +1,933% | +$36.1K | ﹤0.01% | 932 |
|
|
2020
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 2235 |
|
|
2019
Q4 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 1444 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2338 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2337 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | – | – | 2433 |
|
|
2018
Q1 | $0 | Buy |
+100
| New | – | ﹤0.01% | 2660 |
|
|
2017
Q4 | – | Sell |
-100
| Closed | – | – | 3015 |
|
|
2017
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 3264 |
|
|
2017
Q2 | $0 | Sell |
100
-453
| -82% | – | ﹤0.01% | 3465 |
|
|
2017
Q1 | $2K | Sell |
553
-800
| -59% | -$2.89K | ﹤0.01% | 2612 |
|
|
2016
Q4 | $6K | Buy |
+1,353
| New | +$6K | ﹤0.01% | 2447 |
|
|
2016
Q3 | – | Sell |
-953
| Closed | -$5K | – | 3519 |
|
|
2016
Q2 | $5K | Sell |
953
-1,400
| -59% | -$7.35K | ﹤0.01% | 2432 |
|
|
2016
Q1 | $12K | Buy |
2,353
+2,314
| +5,933% | +$11.8K | ﹤0.01% | 1977 |
|
|
2015
Q4 | $0 | Buy |
+39
| New | – | ﹤0.01% | 3389 |
|